Skip to content
Disclosery

DC Funds, LP

Follow

13F filer, CIK 1869028, MCLEAN, VA

DC Funds, LP reported $3,109,886 across 3 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-10.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001398344-25-020563

Period
2025-09-30
Reported value
$3.11M
Holdings
3
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001398344-25-020563, largest first. % of portfolio is the value over $3,109,886, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
HOWLWEREWOLF THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 589,102 shares; 2024Q4: 589,102 shares; 2025Q1: 589,102 shares; 2025Q2: 589,102 shares; 2025Q3: 589,102 shares 589,102$1.16M37.32%0Timeline
TCRXTSCAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 630,000 shares; 2024Q4: 630,000 shares; 2025Q1: 630,000 shares; 2025Q2: 630,000 shares; 2025Q3: 630,000 shares 630,000$1.15M36.87%0Timeline
BRNSBARINTHUS BIOTHERAPEUTICS PLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 642,204 shares; 2024Q4: 642,204 shares; 2025Q1: 642,204 shares; 2025Q2: 642,204 shares; 2025Q3: 642,204 shares 642,204$803K25.81%0Timeline

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001398344-25-020563 base2025-11-10acceptance time not in the bulk data set